Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 6/20 | 1.00 |
| ▸ | CYP17A1 | P05093 | 5/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.70 |
| ▸ | G6PD | P11413 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | SERPINA6 | P08185 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | GUSB | P08236 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | AR | P10275 | 1/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17776491 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL142941 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL27808104 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL658688 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL735471 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL18373712 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL20457510 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL27633183 | 1.00 | SHBG (1.00) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| Sulfuric Acid SCHEMBL1576876 | 0.96 | SHBG (0.91) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A | |
| SCHEMBL31086698 | 0.92 | SHBG (0.85) | SHBGCYP17A1ALDH1A1CYP2C9HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1408 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260140124-A1 | PCOS STRATIFICATION | THE UNIVERSITY OF BIRMINGHAM (GB) | 2026-05-21 | — | — | US | claimed |
| EP-4740024-A1 | ENDOMETRIOSIS MARKERS AND METHODS OF DIAGNOSING ENDOMETRIOSIS | The University Court Of The University of Edinburgh (GB) | 2026-05-13 | — | — | EP | claimed |
| CN-122017085-A | Method for simultaneously detecting multiple steroid hormones in serum | 北京大学第三医院（北京大学第三临床医学院） | 2026-05-12 | — | — | CN | claimed |
| EP-4605743-A1 | PCOS STRATIFICATION | The University of Birmingham (GB) | 2025-08-27 | — | — | EP | claimed |
| EP-3486648-B1 | MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA | QUEST DIAGNOSTICS INVEST INC (US) | 2025-04-30 | — | — | EP | claimed |
| WO-2025008638-A1 | ENDOMETRIOSIS MARKERS AND METHODS OF DIAGNOSING ENDOMETRIOSIS | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2025-01-09 | — | — | WO | claimed |
| CN-115343398-B | Kit and method for simultaneously measuring multiple steroid hormones in serum | 吉林大学第一医院 | 2024-12-24 | — | — | CN | claimed |
| CN-119125354-A | Method and kit for measuring various steroid hormones in body fluid by liquid chromatography-mass spectrometry technology | 浙江博圣生物技术股份有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-119125357-A | Kit for simultaneously detecting multiple steroid hormones in dried blood spots based on liquid chromatography-mass spectrometry and application of kit | 浙江博圣生物技术股份有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118961985-A | Kit and method for simultaneously detecting 18 steroid hormones based on double-derivative technology | 上海万子健医学检验实验室有限公司 | 2024-11-15 | — | — | CN | claimed |
| WO-1999040203-A1 | YEAST STRAINS WITH INTERRUPTED ATF2 GENE AND USES | HOECHST MARION ROUSSEL (FR) | 1999-08-12 | — | — | WO | claimed |
| EP-0594581-B1 | PRODUCTION OF GLYCOSIDES, ESPECIALLY OF STEROIDAL GLYCOSIDES | KLEMKE RUDOLF ERICH (DE) | 1998-07-01 | — | — | EP | claimed |
| EP-0649472-A4 | FUSION PROTEINS COMPRISING EUKARYOTIC CYTOCHROME P450 FUSED TO A REDUCTASE. | UNIV TEXAS (US) | 1997-03-19 | — | — | EP | claimed |
| EP-0649472-A1 | FUSION PROTEINS COMPRISING EUKARYOTIC CYTOCHROME P450 FUSED TO A REDUCTASE | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-04-26 | — | — | EP | claimed |
| EP-0594581-A1 | PRODUCTION OF GLYCOSIDES, ESPECIALLY OF STEROIDAL GLYCOSIDES | Klemke, Rudolf Erich, Dipl.-Chem. (DE) | 1994-05-04 | — | — | EP | claimed |
| WO-1994001568-A1 | FUSION PROTEINS COMPRISING EUKARYOTIC CYTOCHROME P450 FUSED TO A REDUCTASE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-01-20 | — | — | WO | claimed |
| US-5137822-A | Transformed yeasts having steroid-hydroxylase activity and process for hydroxylation of steroids using the said transformed yeasts | DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY AN ORGAN OF THE MINISTRY OF INDUSTRIAL TRADE AND INDUSTRY OF JAPAN (JP) | 1992-08-11 | — | — | US | claimed |
| WO-1992013076-A1 | METHODS AND COMPOSITIONS FOR THE EXPRESSION OF BIOLOGICALLY ACTIVE EUKARYOTIC CYTOCHROME P450S IN BACTERIA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-08-06 | — | — | WO | claimed |
| WO-1991011452-A1 | PRODUCTION OF GLYCOSIDES, ESPECIALLY OF STEROIDAL GLYCOSIDES | 'HARRIER' GMBH GESELLSCHAFT FÜR DEN VERTRIEB MEDIZINISCHER UND TECHNISCHER GERÄTE (DE) | 1991-08-08 | — | — | WO | claimed |
| US-4321208-A | Preparation of directly iodinated steroid hormones and related compounds | SAHADEVAN VELAYUDHAN | 1982-03-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260140124-A1 | PCOS STRATIFICATION | HSD17B3, AKR1C3, HSD17B11 | SHBG 34/4885CYP17A1 15/4885ALDH1A1 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.